33526143|t|Delta9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes.
33526143|a|Delta9-Tetrahydrocannabivarin (THCV) is a cannabis-derived compound with unique properties that set it apart from the more common cannabinoids, such as Delta9-tetrahydrocannabinol (THC). The main advantage of THCV over THC is the lack of psychoactive effects. In rodent studies, THCV decreases appetite, increases satiety, and up-regulates energy metabolism, making it a clinically useful remedy for weight loss and management of obesity and type 2 diabetic patients. The distinctions between THCV and THC in terms of glycemic control, glucose metabolism, and energy regulation have been demonstrated in previous studies. Also, the effect of THCV on dyslipidemia and glycemic control in type 2 diabetics showed reduced fasting plasma glucose concentration when compared to a placebo group. In contrast, THC is indicated in individuals with cachexia. However, the uniquely diverse properties of THCV provide neuroprotection, appetite suppression, glycemic control, and reduced side effects, etc.; therefore, making it a potential priority candidate for the development of clinically useful therapies in the future. Hopefully, THCV could provide an optional platform for the treatment of life-threatening diseases.
33526143	0	29	Delta9-Tetrahydrocannabivarin	Chemical	MESH:C003403
33526143	31	35	THCV	Chemical	MESH:C003403
33526143	106	113	obesity	Disease	MESH:D009765
33526143	118	126	diabetes	Disease	MESH:D003920
33526143	128	157	Delta9-Tetrahydrocannabivarin	Chemical	MESH:C003403
33526143	159	163	THCV	Chemical	MESH:C003403
33526143	258	270	cannabinoids	Chemical	MESH:D002186
33526143	280	307	Delta9-tetrahydrocannabinol	Chemical	MESH:D013759
33526143	309	312	THC	Chemical	MESH:D013759
33526143	337	341	THCV	Chemical	MESH:C003403
33526143	347	350	THC	Chemical	MESH:D013759
33526143	407	411	THCV	Chemical	MESH:C003403
33526143	528	539	weight loss	Disease	MESH:D015431
33526143	558	565	obesity	Disease	MESH:D009765
33526143	570	585	type 2 diabetic	Disease	MESH:D003924
33526143	586	594	patients	Species	9606
33526143	621	625	THCV	Chemical	MESH:C003403
33526143	630	633	THC	Chemical	MESH:D013759
33526143	664	671	glucose	Chemical	MESH:D005947
33526143	770	774	THCV	Chemical	MESH:C003403
33526143	778	790	dyslipidemia	Disease	MESH:D050171
33526143	815	831	type 2 diabetics	Disease	MESH:D003924
33526143	862	869	glucose	Chemical	MESH:D005947
33526143	931	934	THC	Chemical	MESH:D013759
33526143	968	976	cachexia	Disease	MESH:D002100
33526143	1022	1026	THCV	Chemical	MESH:C003403
33526143	1253	1257	THCV	Chemical	MESH:C003403
33526143	Negative_Correlation	MESH:C003403	MESH:D003924
33526143	Comparison	MESH:C003403	MESH:D013759
33526143	Negative_Correlation	MESH:D013759	MESH:D002100
33526143	Negative_Correlation	MESH:C003403	MESH:D009765
33526143	Negative_Correlation	MESH:C003403	MESH:D050171
33526143	Negative_Correlation	MESH:C003403	MESH:D015431
33526143	Negative_Correlation	MESH:C003403	MESH:D003920
33526143	Negative_Correlation	MESH:C003403	MESH:D005947

